Share on StockTwits

U.S. Physical Therapy (NASDAQ:USPH) Director Mark J. Brookner sold 549 shares of the stock on the open market in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $35.82, for a total value of $19,665.18. Following the completion of the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $1,791,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of U.S. Physical Therapy (NASDAQ:USPH) opened at 34.94 on Thursday. U.S. Physical Therapy has a 52-week low of $27.80 and a 52-week high of $37.25. The stock’s 50-day moving average is $35.3 and its 200-day moving average is $33.3. The company has a market cap of $427.5 million and a price-to-earnings ratio of 32.04.

U.S. Physical Therapy (NASDAQ:USPH) last announced its earnings results on Thursday, August 7th. The company reported $0.52 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.44 by $0.08. The company had revenue of $66.90 million for the quarter, compared to the consensus estimate of $74.25 million. During the same quarter last year, the company posted $0.42 earnings per share. U.S. Physical Therapy’s revenue was up 16.9% compared to the same quarter last year. On average, analysts predict that U.S. Physical Therapy will post $1.70 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, September 5th. Shareholders of record on Monday, August 18th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.37%. The ex-dividend date is Thursday, August 14th.

Separately, analysts at Jefferies Group raised their price target on shares of U.S. Physical Therapy from $38.00 to $40.00 in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. U.S. Physical Therapy presently has a consensus rating of “Buy” and a consensus target price of $36.80.

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Receive News & Ratings for US Physical Therapy Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for US Physical Therapy Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.